RAFAEL VÍCTOR
ARROYO GONZÁLEZ
Investigador en el periodo 2009-2016
María Inmaculada
Dominguez Mozo
Publicaciones en las que colabora con María Inmaculada Dominguez Mozo (16)
2021
2020
2017
-
Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort
European Journal of Clinical Investigation, Vol. 47, Núm. 2, pp. 158-166
2016
-
Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients
European Journal of Neurology, Vol. 23, Núm. 1, pp. 182-189
2014
-
Anti-human herpesvirus 6A/B IgG correlates with relapses and progression in multiple sclerosis
PLoS ONE, Vol. 9, Núm. 8
-
HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV
Retrovirology, Vol. 11, Núm. 1
-
Toll-like receptor-9 in Spanish multiple sclerosis patients: An association with the gender
European Journal of Neurology, Vol. 21, Núm. 3, pp. 537-540
2013
-
Anti-JCV antibodies detection and JCV DNA levels in PBMC, serum and urine in a cohort of spanish multiple sclerosis patients treated with natalizumab
Journal of Neuroimmune Pharmacology, Vol. 8, Núm. 5, pp. 1277-1286
-
The DNA Copy Number of Human Endogenous Retrovirus-W (MSRV-Type) Is Increased in Multiple Sclerosis Patients and Is Influenced by Gender and Disease Severity
PLoS ONE, Vol. 8, Núm. 1
2012
2011
-
CD46 in a Spanish cohort of multiple sclerosis patients: Genetics, mRNA expression and response to interferon-beta treatment
Multiple Sclerosis Journal, Vol. 17, Núm. 5, pp. 513-520
-
Herpesvirus active replication in multiple sclerosis: A genetic control?
Journal of the Neurological Sciences, Vol. 311, Núm. 1-2, pp. 98-102
-
Human herpesvirus 6 and effectiveness of interferon beta 1b in multiple sclerosis patients
European Journal of Neurology, Vol. 18, Núm. 8, pp. 1027-1035
2010
-
MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients
European Journal of Neurology, Vol. 17, Núm. 1, pp. 129-135
-
Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: A two-year follow-up study
European Journal of Neurology, Vol. 17, Núm. 3, pp. 470-478
2009
-
CD46 expression and HHV-6 infection in patients with multiple sclerosis
Acta Neurologica Scandinavica, Vol. 120, Núm. 4, pp. 246-250